Margolis Seminars in Health Policy & Management are held approximately every other Friday from 12-1:30 pm
Attendees include faculty, staff, and students from departments across Duke, as well as (by videoconference) the Margolis Center office in Washington, DC. The seminars aim to connect the Duke-wide health policy community, and to help people form, develop, and shape their health policy-related work. Most seminars cover research or policy analysis in progress, while others include presentations by faculty, staff, and visitors on significant newly-released research or legislation/regulations. If you are interested in attending or presenting at seminar, or wish to be added to the seminar email list, please email Hilary Campbell.
2018 Seminar Dates
January 5, 19
February 16
March 2, 16, 30
April 20
May 4, 18
June 1
July 6
August 3, 17
September 7, 21
October 5, 19
November 2
December 7
Past Speakers and Topics
March 30, 2018
Controlling Costs in Massachusetts
Stuart Altman (Brandeis University, The Heller School for Social Policy and Management)
New Cost Data & Brainstorm
Chad Mather (Duke Orthopaedic Surgery)
March 16, 2018
Shared decision making for critically ill infants
Monica Lemmon
Cost-Effectiveness Analysis of Financial Incentives for Smoking Cessation in NC Medicaid
Madhu Vulimiri
March 2, 2018
Policy Implications for Scaling Research Studies with Physical Therapists as Entry Level Providers
Adam Goode, Janet Bettger, and Kyle Covington
Ten Tips for Working with the Media
Ellen de Graffenreid
February 16, 2018
Diagnostic Innovation: Patent and Regulatory Considerations
Arti Rai
Value-of-Information Analysis in Health Policy: Should I Look Some More Before I Leap?
Evan Myers
January 26, 2018
Medicare Shared Savings Program: Patient Outcomes Following Ischemic Stroke
Brystana Kaufman (DCRI Fellow | PhD Candidate)
The Public Health Impact of FDA Safety Labeling Changes: Findings from a Literature Review
Liz Richardson & Colleagues (Duke-Margolis DC Office)
January 5, 2018
Tapping Margolis expertise on serious illness care inside ACOs
Robert Saunders
Overviews of recently funded projects:
Value of Hope Project (PhRMA Foundation) -- Shelby Reed
Center for Child and Family Policy Collaboration Project (Duke Endowment) -- Andrew Olsen
Open Discussion with Mark McClellan on federal health reform issues (CHIP, Medicaid, government research funding, etc.)
December 8, 2017
Joining Forces: How Advocates Can Lead Researchers Out of the Ivory Tower co-sponsored by the Duke Council on Race and Ethnicity (DCORE) and the Duke-Margolis Center for Health Policy.
Donna Biederman, Assistant Professor of Nursing, Duke University
Emily Carmody, NC Coalition to End Homelessness
Mina R. Silberberg, Associate Professor in Community and Family Medicine, Duke University
November 10, 2017
APMs at Duke: a view from the trenches
George Cheely
Impact of the Affordable Care Act on Insurance Status of Non-Elderly US Adults with Atherosclerotic Cardiovascular Disease
Haider Warraich
October 27, 2017
The Duke Joint Health Program: a new care model to address costs and utilization for the care of patients with hip or knee osteoarthritis
Chad Mather, Jonathan O’Donnell, Morven Ross, Bill Jiranek
State Choices for CSR Non-payment
David Anderson
October 13, 2017
Quality in Cancer Care: Evaluating the Commission on Cancer’s Quality Measures
Rachel Greenup/Daniel Nussbaum/team members
Politics of CHW Scope and Medication Management in the Community
Bradi Granger
September 29, 2017
The Pharma Social Contract
Steve Usdin, BioCentury
Rationing by Roadblocks: Impact of prior authorization and copays on access to PCSK9 inhibitors
Ann Marie Navar
Recent CMMI Payment Reform Announcement
Mark McClellan
September 15, 2017
Managed Care Reform and Prospects for Medicaid Expansion in North Carolina
Andrew Olson
Strategic Vision for Multi-State Data Collaboration: Starting with Opioids
Aaron McKethan
August 4, 2017
ACA Repeal and Replace: What’s Next
Mark McClellan, Rob Saunders
Building a Patient Centered Home for Osteoarthritis
Chad Mather, Jonathan O’Donnell
Mexican Health System Data
Ramon Torras
Defining a Crosswalk from Health Data to Health and Policy
Victoria Christian
July 14, 2017
Defensive Medicine: Evidence from Military Immunity
Michael Frakes
Incentivizing Healthy Behaviors in Medicaid Programs: Is there a secret sauce?
Charlene Wong, Rob Saunders, Will Bleser, and Megan Moore
June 16, 2017
Brief description of the Society of Actuaries and its role in all commercial insurance planning. Overview of white paper; Attribution: Basis for All Value Based Care - attribution as the main way to show who’s responsible and accountable for performance and technical insurance risk.
Matthew Harker
Keeping Up with Consumers: How can mHealth apps and wearables help evaluate medical products?
Christina Silcox, Jonathan Bryan, and Isha Sharma
We have a decade of evidence regarding the utility of Community Health Workers in the management of chronic disease. How do we take the leap into APMs in advance of the transition from fee-for-service to capitation? What are we missing?
Bradi Granger and Andrew Olson
June 2, 2017
A Multi-Methods Examination of Accountable Care Organizations: What affects ACO performance and survival?
Will Bleser
Daily Financial Incentives to Improve Glucose Monitoring Adherence and Glycemic Control among Adolescents and Young Adults with Type 1 Diabetes: A Randomized Controlled Trial
Charlene Wong
May 19, 2017
The Costs of Healthcare Billing
Barak Richman
How does Medicare Reimbursement Affect Drug Prices? Question for the group: If we placed a cap on U.S. drug prices, what should it be?
David Ridley
May 5, 2017
Integrated Payment and Delivery Innovations to Address US Healthcare Needs
Krishna Udayakumar
Supporting Biomedical and Care Delivery Policy and Innovation in Singapore and Southeast Asia
Krishna Udayakumar
Discussion of CPM (contralateral prophylactic mastectomy) between Patients and Surgeons
Vinay Choksi
April 14, 2017
Insurance Carrier Pricing Strategies for the Subsidized Exchange Market
Dave Anderson
Current policy issues related to off-label communication of pharmaceuticals
Morgan Romine
March 31, 2017
Measuring the Value of Hope
Shelby Reed
Intervention to Promote Financial Literacy Among Cancer Patients
Yousuf Zafar
March 17, 2017
Challenges in Measuring Patient Data
Heather Colvin
Study Recruitment Challenges
Matt Harker
American Health Care Act Discussion
Rob Saunders
February 24, 2017
Synthesizing Evidence and Cost-Effectiveness Analyses to Inform Value-Based Frameworks
Gillian Sanders-Schmidler
ACA Reform Status and Next Steps – Political and Analytic
Mark McClellan